TITLE

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?

AUTHOR(S)
Deane, Adam M.; Horowitz, Michael
PUB. DATE
February 2014
SOURCE
Diabetes Care;Feb2014, Vol. 37 Issue 2, pe40
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
The authors comment on narratives relating to the use of incretin-based therapy for hospitalized patients with hyperglycemia. They describe the results of their mechanistic studies that evaluated incretin-based therapies in the critically ill. They also emphasize the use of insulin in hyperglycemia treatment.
ACCESSION #
93918084

 

Related Articles

  • Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes? Schwartz, Stanley; DeFronzo, Ralph A. // Diabetes Care;Feb2014, Vol. 37 Issue 2, pe42 

    A response to a commentary on a study that investigated the use of incretin-based therapy for hospitalized patients with hyperglycemia is presented. They assert that the results support their claim that glucagon-like peptide 1 (GLP-1) therapy represents a safe and effective intervention for...

  • Does glycemic control with insulin therapy play a role for critically ill patients in hospital? Patel, Arpita H.; Pittas, Anastassios G. // CMAJ: Canadian Medical Association Journal;3/28/2006, Vol. 174 Issue 7, p917 

    Analyzes the significance of glycemic control to critically ill hospital patients. Use of insulin therapy to control hyperglycemia; Overview of studies on the clinical importance of glycemic control; Mechanisms that explain the benefits of insulin therapy and glycemic control in critically ill...

  • Inpatient Management of Hyperglycemia and Diabetes. Magaji, Vasudev; Johnston, Jann M. // Clinical Diabetes;Winter2011, Vol. 29 Issue 1, p3 

    Control of hyperglycemia in hospitalized patients is important for optimal clinical outcomes, but can be very challenging. This article provides practical recommendations for insulin therapy for common situations that arise during hospitalization.

  • Intensive insulin therapy reduced the incidence of neurologic complications in critically ill patients: COMMETARY. Bleck, Thomas P. // ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p20 

    This article comments on a study conducted to examine the efficacy of intensive insulin therapy in reducing the incidence of neurologic complications in critically ill patients. In a surgical intensive care unit (ICU) population, intensive insulin therapy decreased mortality, bloodstream...

  • End-of-life care in India. Mani, Raj; Mani, Raj Kumar // Intensive Care Medicine;Jul2006, Vol. 32 Issue 7, p1066 

    The article reports on intensive care and the use of life support systems in India. The impact of continuing futile therapies is serious. The standards of medical care are different between the public and private hospitals. Intensive care can only be afforded by the middle- to high-income...

  • Continuing Education.  // American Journal of Health-System Pharmacy;5/15/2005 Supplement 2, Vol. 62, pS31 

    Presents a quiz about the treatment options and formulary considerations in the management of acid suppression in critically ill patients.

  • Validation of a prognostic score in critically ill patients undergoing transport. Bion, J. F.; Edlin, S. A.; Ramsay, G.; McCabe, S.; Ledingham, I. McA. // British Medical Journal (Clinical Research Edition);8/17/1985, Vol. 291 Issue 6493, p432 

    Fifty consecutive critically ill patients transported between hospitals by a mobile intensive care team were assessed prospectively using a modification of the acute physiology and chronic health evaluation (APACHE II) sickness scoring system. Assessments were made before and after...

  • Intensive Insulin Therapy in Critical Care Settings. Eastman, Darla Klug; Bottenberg, Michelle M.; Hegge, Karly A.; Ourth, Heather; Kabadi, Udaya // Current Clinical Pharmacology;Jan2009, Vol. 4 Issue 1, p71 

    Hyperglycemia in hospitalized patients has been shown to increase both morbidity and mortality, regardless of the presence of preexisting diabetes. In order to achieve recommended glycemic goals, many patients require the use of intravenous insulin therapy in the critical care setting. Following...

  • Stress hyperglycaemia in critically ill patients; Potential role of incretin hormones; a preliminary study. Llompart-Pou, J. A.; Fernández-de-Castillo2, A. G.; Burguera, B.; Pérez-Bárcena, J.; Marsé, P.; Rodríguez-Yago, M.; Barcelo, A.; Raurich, J. M. // Nutricion Hospitalaria;ene/feb2012, Vol. 27 Issue 1, p130 

    Background: Stress hyperglycaemia is common in the intensive care unit (ICU) setting and has been related to a worst outcome. Objective: The objective was to characterize the association of glucoregulatory hormones, mainly incretins, with the levels of glycaemia, and its relationship with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics